| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Streptococcus pneumoniae | 72 | 2018 | 330 | 6.240 |
Why?
|
| Pneumococcal Infections | 55 | 2018 | 241 | 5.580 |
Why?
|
| Staphylococcal Infections | 51 | 2023 | 672 | 4.520 |
Why?
|
| Staphylococcus aureus | 40 | 2023 | 548 | 3.410 |
Why?
|
| Pneumococcal Vaccines | 32 | 2018 | 161 | 3.150 |
Why?
|
| Community-Acquired Infections | 26 | 2018 | 285 | 1.920 |
Why?
|
| Anti-Bacterial Agents | 56 | 2018 | 2992 | 1.820 |
Why?
|
| Microbial Sensitivity Tests | 57 | 2018 | 994 | 1.790 |
Why?
|
| Bacteremia | 27 | 2023 | 689 | 1.500 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 17 | 2018 | 308 | 1.420 |
Why?
|
| Penicillin Resistance | 28 | 2005 | 69 | 1.390 |
Why?
|
| Serotyping | 38 | 2018 | 166 | 1.160 |
Why?
|
| Infant | 116 | 2018 | 13310 | 1.070 |
Why?
|
| Haemophilus influenzae | 30 | 2011 | 144 | 1.020 |
Why?
|
| Child, Preschool | 113 | 2018 | 16273 | 1.010 |
Why?
|
| Population Surveillance | 11 | 2018 | 627 | 0.970 |
Why?
|
| Hospitals, Pediatric | 14 | 2018 | 773 | 0.950 |
Why?
|
| Osteomyelitis | 12 | 2017 | 236 | 0.930 |
Why?
|
| Mupirocin | 3 | 2015 | 25 | 0.910 |
Why?
|
| Vaccines, Conjugate | 12 | 2018 | 76 | 0.770 |
Why?
|
| Child | 115 | 2018 | 29154 | 0.730 |
Why?
|
| Vancomycin | 11 | 2017 | 273 | 0.700 |
Why?
|
| Pneumonia, Pneumococcal | 9 | 2017 | 74 | 0.690 |
Why?
|
| Penicillins | 12 | 2016 | 143 | 0.670 |
Why?
|
| Meningitis, Pneumococcal | 11 | 2015 | 36 | 0.660 |
Why?
|
| Haemophilus Infections | 15 | 2003 | 103 | 0.630 |
Why?
|
| Chlorhexidine | 3 | 2017 | 88 | 0.630 |
Why?
|
| Otitis Media | 9 | 2015 | 65 | 0.540 |
Why?
|
| Methicillin Resistance | 16 | 2015 | 147 | 0.530 |
Why?
|
| Soft Tissue Infections | 6 | 2015 | 102 | 0.530 |
Why?
|
| Infant, Newborn | 66 | 2018 | 8223 | 0.520 |
Why?
|
| Empyema | 4 | 2010 | 28 | 0.520 |
Why?
|
| Meningococcal Vaccines | 5 | 2006 | 31 | 0.510 |
Why?
|
| Carrier State | 6 | 2011 | 90 | 0.500 |
Why?
|
| Sodium Hypochlorite | 1 | 2013 | 12 | 0.480 |
Why?
|
| Serogroup | 7 | 2018 | 50 | 0.480 |
Why?
|
| Baths | 1 | 2013 | 16 | 0.480 |
Why?
|
| Hygiene | 1 | 2013 | 24 | 0.480 |
Why?
|
| Disinfection | 1 | 2013 | 42 | 0.470 |
Why?
|
| Disinfectants | 1 | 2013 | 35 | 0.470 |
Why?
|
| Streptococcal Infections | 8 | 2001 | 280 | 0.470 |
Why?
|
| Adolescent | 64 | 2018 | 31252 | 0.450 |
Why?
|
| Cross Infection | 11 | 2016 | 544 | 0.430 |
Why?
|
| Staphylococcal Skin Infections | 5 | 2014 | 53 | 0.430 |
Why?
|
| Meningococcal Infections | 3 | 2013 | 21 | 0.420 |
Why?
|
| Humans | 206 | 2023 | 261506 | 0.410 |
Why?
|
| Bacterial Typing Techniques | 7 | 2011 | 139 | 0.400 |
Why?
|
| Utah | 11 | 2016 | 43 | 0.400 |
Why?
|
| Arthritis, Infectious | 4 | 2017 | 68 | 0.400 |
Why?
|
| Mastoiditis | 3 | 2015 | 26 | 0.400 |
Why?
|
| Clindamycin | 7 | 2011 | 50 | 0.390 |
Why?
|
| Heptavalent Pneumococcal Conjugate Vaccine | 10 | 2016 | 28 | 0.380 |
Why?
|
| Male | 107 | 2018 | 123000 | 0.380 |
Why?
|
| Empyema, Pleural | 3 | 2011 | 48 | 0.380 |
Why?
|
| Ampicillin | 11 | 1991 | 58 | 0.370 |
Why?
|
| Drug Resistance, Bacterial | 14 | 2017 | 418 | 0.370 |
Why?
|
| Anti-Infective Agents, Local | 3 | 2017 | 121 | 0.370 |
Why?
|
| Female | 112 | 2018 | 141928 | 0.360 |
Why?
|
| Cephalosporins | 12 | 2001 | 148 | 0.360 |
Why?
|
| Texas | 23 | 2018 | 6311 | 0.360 |
Why?
|
| Nasopharynx | 2 | 2005 | 119 | 0.340 |
Why?
|
| Incidence | 24 | 2016 | 5673 | 0.320 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 1 | 2014 | 923 | 0.310 |
Why?
|
| Immunocompromised Host | 5 | 2016 | 698 | 0.310 |
Why?
|
| Sinusitis | 4 | 2014 | 131 | 0.310 |
Why?
|
| Multilocus Sequence Typing | 5 | 2016 | 58 | 0.310 |
Why?
|
| Shigella dysenteriae | 2 | 1998 | 3 | 0.300 |
Why?
|
| Ceftriaxone | 11 | 2016 | 67 | 0.300 |
Why?
|
| Dysentery, Bacillary | 2 | 1998 | 11 | 0.300 |
Why?
|
| Meningitis, Haemophilus | 9 | 1995 | 34 | 0.300 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 4 | 2016 | 202 | 0.290 |
Why?
|
| Chloramphenicol | 7 | 1991 | 28 | 0.290 |
Why?
|
| Methicillin | 9 | 2010 | 49 | 0.280 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 10 | 2015 | 128 | 0.280 |
Why?
|
| Leukocidins | 7 | 2018 | 46 | 0.270 |
Why?
|
| Prevalence | 9 | 2018 | 3260 | 0.270 |
Why?
|
| Exotoxins | 7 | 2018 | 77 | 0.270 |
Why?
|
| Molecular Epidemiology | 6 | 2013 | 246 | 0.260 |
Why?
|
| Bacteriological Techniques | 4 | 2016 | 121 | 0.260 |
Why?
|
| Cephalosporin Resistance | 4 | 2001 | 16 | 0.260 |
Why?
|
| England | 4 | 2023 | 75 | 0.260 |
Why?
|
| Immunization Schedule | 3 | 2016 | 117 | 0.260 |
Why?
|
| Cefotaxime | 6 | 2001 | 34 | 0.250 |
Why?
|
| Meningitis, Bacterial | 5 | 2017 | 89 | 0.250 |
Why?
|
| Pneumonia, Bacterial | 1 | 2006 | 130 | 0.250 |
Why?
|
| United States | 26 | 2018 | 15433 | 0.250 |
Why?
|
| Drug Resistance, Microbial | 12 | 2000 | 218 | 0.250 |
Why?
|
| Genotype | 9 | 2018 | 4109 | 0.240 |
Why?
|
| Meningitis | 8 | 1990 | 112 | 0.240 |
Why?
|
| State Medicine | 1 | 2023 | 16 | 0.240 |
Why?
|
| Cellulitis | 4 | 2011 | 72 | 0.240 |
Why?
|
| Hospitals | 4 | 2023 | 485 | 0.240 |
Why?
|
| Erythromycin | 2 | 2003 | 22 | 0.240 |
Why?
|
| Prospective Studies | 31 | 2016 | 12873 | 0.240 |
Why?
|
| Retrospective Studies | 39 | 2018 | 37905 | 0.230 |
Why?
|
| Licensure | 1 | 2003 | 11 | 0.230 |
Why?
|
| Organ Transplantation | 2 | 2016 | 191 | 0.230 |
Why?
|
| Ketolides | 1 | 2003 | 4 | 0.230 |
Why?
|
| DNA, Bacterial | 7 | 2010 | 558 | 0.230 |
Why?
|
| Measles | 3 | 1997 | 36 | 0.220 |
Why?
|
| Sepsis | 8 | 2005 | 652 | 0.220 |
Why?
|
| DNA Fingerprinting | 5 | 2010 | 167 | 0.220 |
Why?
|
| Drug Resistance, Multiple | 1 | 2003 | 204 | 0.220 |
Why?
|
| Disease Outbreaks | 4 | 1998 | 415 | 0.210 |
Why?
|
| Labyrinthitis | 3 | 1991 | 10 | 0.210 |
Why?
|
| Fimbriae, Bacterial | 7 | 1992 | 66 | 0.210 |
Why?
|
| Antibodies, Bacterial | 9 | 2003 | 380 | 0.210 |
Why?
|
| Polymerase Chain Reaction | 10 | 2011 | 3203 | 0.200 |
Why?
|
| Bacterial Toxins | 7 | 2018 | 228 | 0.200 |
Why?
|
| Infant, Low Birth Weight | 5 | 1996 | 181 | 0.190 |
Why?
|
| Premedication | 2 | 1991 | 135 | 0.190 |
Why?
|
| Chi-Square Distribution | 7 | 2013 | 1323 | 0.190 |
Why?
|
| Measles Vaccine | 2 | 1997 | 10 | 0.190 |
Why?
|
| Bacterial Infections | 7 | 2011 | 479 | 0.190 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2001 | 163 | 0.190 |
Why?
|
| Cluster Analysis | 4 | 2011 | 1053 | 0.190 |
Why?
|
| Ear, Middle | 2 | 2015 | 48 | 0.190 |
Why?
|
| Intestinal Perforation | 2 | 1991 | 102 | 0.180 |
Why?
|
| Oxazoles | 2 | 1999 | 60 | 0.180 |
Why?
|
| Oxazolidinones | 2 | 1999 | 60 | 0.180 |
Why?
|
| Child, Hospitalized | 2 | 2002 | 62 | 0.170 |
Why?
|
| HIV Infections | 1 | 2012 | 2134 | 0.170 |
Why?
|
| Acetamides | 2 | 1999 | 113 | 0.170 |
Why?
|
| Appendicitis | 2 | 1991 | 169 | 0.170 |
Why?
|
| Orbital Cellulitis | 1 | 2018 | 18 | 0.160 |
Why?
|
| Recurrence | 8 | 2016 | 4758 | 0.160 |
Why?
|
| Statistics, Nonparametric | 5 | 2013 | 980 | 0.160 |
Why?
|
| Neutrophils | 8 | 2013 | 835 | 0.160 |
Why?
|
| Cerebral Ventriculitis | 1 | 2017 | 13 | 0.160 |
Why?
|
| Arthritis | 1 | 1998 | 139 | 0.160 |
Why?
|
| Leukocyte Count | 6 | 2013 | 684 | 0.150 |
Why?
|
| Citrobacter | 5 | 1992 | 22 | 0.150 |
Why?
|
| Immunization, Secondary | 1 | 1997 | 110 | 0.150 |
Why?
|
| Ceftizoxime | 1 | 1997 | 3 | 0.150 |
Why?
|
| Ticarcillin | 2 | 1991 | 9 | 0.150 |
Why?
|
| Zimbabwe | 6 | 1998 | 10 | 0.140 |
Why?
|
| Patient Admission | 1 | 2018 | 220 | 0.140 |
Why?
|
| Vaccination | 6 | 2011 | 1123 | 0.140 |
Why?
|
| Bacterial Adhesion | 4 | 1993 | 147 | 0.140 |
Why?
|
| Dexamethasone | 4 | 1998 | 1450 | 0.140 |
Why?
|
| Age Distribution | 5 | 2010 | 698 | 0.140 |
Why?
|
| Meningitis, Meningococcal | 3 | 2013 | 17 | 0.140 |
Why?
|
| Hospitalization | 3 | 2017 | 2083 | 0.130 |
Why?
|
| Retropharyngeal Abscess | 1 | 2015 | 11 | 0.130 |
Why?
|
| Mastoid | 1 | 2015 | 26 | 0.130 |
Why?
|
| Drug Therapy, Combination | 11 | 1998 | 2315 | 0.130 |
Why?
|
| Cephamycins | 7 | 1983 | 13 | 0.130 |
Why?
|
| Gentamicins | 2 | 1995 | 90 | 0.130 |
Why?
|
| Haemophilus Vaccines | 2 | 1992 | 40 | 0.130 |
Why?
|
| Bacteria | 2 | 1994 | 611 | 0.130 |
Why?
|
| Bacterial Vaccines | 2 | 1992 | 103 | 0.120 |
Why?
|
| Pandemics | 1 | 2023 | 1559 | 0.120 |
Why?
|
| Radiography, Interventional | 1 | 2016 | 305 | 0.120 |
Why?
|
| Adult | 24 | 2015 | 77950 | 0.120 |
Why?
|
| Deafness | 3 | 1998 | 82 | 0.120 |
Why?
|
| Diterpenes | 1 | 2014 | 111 | 0.120 |
Why?
|
| Hospital Mortality | 1 | 1998 | 1274 | 0.110 |
Why?
|
| Down Syndrome | 1 | 2015 | 226 | 0.110 |
Why?
|
| Single-Blind Method | 1 | 2013 | 409 | 0.110 |
Why?
|
| Cerebral Ventricles | 2 | 1990 | 98 | 0.110 |
Why?
|
| Young Adult | 9 | 2015 | 21445 | 0.110 |
Why?
|
| Rats | 8 | 1991 | 6086 | 0.110 |
Why?
|
| Neisseria meningitidis | 3 | 2013 | 23 | 0.110 |
Why?
|
| Nasal Cavity | 2 | 2011 | 149 | 0.110 |
Why?
|
| Labyrinth Diseases | 2 | 1989 | 6 | 0.110 |
Why?
|
| Tetanus Toxoid | 1 | 1992 | 43 | 0.110 |
Why?
|
| Rifampin | 4 | 1998 | 191 | 0.110 |
Why?
|
| Infant, Newborn, Diseases | 5 | 1982 | 186 | 0.100 |
Why?
|
| Growth Plate | 1 | 2012 | 46 | 0.100 |
Why?
|
| Immunization Programs | 3 | 2015 | 73 | 0.100 |
Why?
|
| Pentoxifylline | 1 | 1991 | 35 | 0.100 |
Why?
|
| Pneumonia, Staphylococcal | 1 | 2011 | 16 | 0.100 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2012 | 297 | 0.100 |
Why?
|
| Membrane Transport Proteins | 1 | 2013 | 244 | 0.100 |
Why?
|
| Clavulanic Acids | 1 | 1991 | 5 | 0.100 |
Why?
|
| Bacterial Proteins | 4 | 2013 | 1029 | 0.100 |
Why?
|
| Fractures, Spontaneous | 1 | 2012 | 84 | 0.100 |
Why?
|
| Acute Disease | 8 | 2012 | 2422 | 0.100 |
Why?
|
| Intercellular Adhesion Molecule-1 | 3 | 1996 | 221 | 0.100 |
Why?
|
| Risk Factors | 11 | 2012 | 17523 | 0.100 |
Why?
|
| Cefuroxime | 5 | 2001 | 15 | 0.100 |
Why?
|
| Treatment Outcome | 15 | 2018 | 32848 | 0.100 |
Why?
|
| Surgical Wound Infection | 2 | 1991 | 450 | 0.090 |
Why?
|
| beta-Lactamase Inhibitors | 1 | 1991 | 52 | 0.090 |
Why?
|
| Sequence Homology | 1 | 2009 | 71 | 0.090 |
Why?
|
| Hemolytic-Uremic Syndrome | 1 | 2010 | 69 | 0.090 |
Why?
|
| Diabetes Complications | 1 | 2012 | 305 | 0.090 |
Why?
|
| Viral Load | 1 | 2012 | 493 | 0.090 |
Why?
|
| Lung Diseases | 3 | 2005 | 717 | 0.090 |
Why?
|
| Bronchodilator Agents | 1 | 1991 | 219 | 0.090 |
Why?
|
| Anti-Infective Agents | 2 | 2015 | 446 | 0.090 |
Why?
|
| Oxacillin | 3 | 1995 | 7 | 0.090 |
Why?
|
| Fever | 2 | 2000 | 497 | 0.090 |
Why?
|
| Lipopolysaccharides | 2 | 1988 | 558 | 0.080 |
Why?
|
| Cochlea | 1 | 1989 | 102 | 0.080 |
Why?
|
| Technetium Tc 99m Medronate | 1 | 2008 | 23 | 0.080 |
Why?
|
| Trimethoprim, Sulfamethoxazole Drug Combination | 1 | 2009 | 72 | 0.080 |
Why?
|
| Moxalactam | 10 | 1988 | 24 | 0.080 |
Why?
|
| Encephalitis | 1 | 1990 | 143 | 0.080 |
Why?
|
| Erythrocytes | 1 | 1990 | 339 | 0.080 |
Why?
|
| Comorbidity | 5 | 2017 | 2352 | 0.080 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2011 | 332 | 0.080 |
Why?
|
| Time Factors | 9 | 2015 | 12926 | 0.080 |
Why?
|
| Sensitivity and Specificity | 5 | 2012 | 4971 | 0.080 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2010 | 242 | 0.080 |
Why?
|
| Anemia, Sickle Cell | 1 | 1992 | 339 | 0.080 |
Why?
|
| Gram-Negative Bacterial Infections | 2 | 2000 | 158 | 0.080 |
Why?
|
| Infant, Premature, Diseases | 4 | 1998 | 245 | 0.080 |
Why?
|
| Arkansas | 2 | 2004 | 58 | 0.080 |
Why?
|
| Animals, Newborn | 6 | 1993 | 1338 | 0.080 |
Why?
|
| Polysaccharides, Bacterial | 5 | 2013 | 67 | 0.080 |
Why?
|
| Staphylococcus | 5 | 1994 | 86 | 0.080 |
Why?
|
| Brain Abscess | 1 | 1988 | 60 | 0.080 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2008 | 305 | 0.070 |
Why?
|
| Rats, Inbred Strains | 5 | 1991 | 410 | 0.070 |
Why?
|
| Culture Media | 4 | 1993 | 319 | 0.070 |
Why?
|
| Catheter-Related Infections | 1 | 2010 | 270 | 0.070 |
Why?
|
| Infant, Premature | 4 | 2007 | 787 | 0.070 |
Why?
|
| Estrogens, Conjugated (USP) | 1 | 2006 | 36 | 0.070 |
Why?
|
| Evaluation Studies as Topic | 3 | 1996 | 418 | 0.070 |
Why?
|
| Streptococcus agalactiae | 5 | 1981 | 107 | 0.070 |
Why?
|
| beta-Lactams | 2 | 2004 | 53 | 0.070 |
Why?
|
| Myositis | 1 | 2006 | 79 | 0.070 |
Why?
|
| Peru | 1 | 2005 | 52 | 0.070 |
Why?
|
| Morbidity | 1 | 2006 | 397 | 0.060 |
Why?
|
| Gastroplasty | 1 | 2005 | 22 | 0.060 |
Why?
|
| Immunization | 2 | 2006 | 397 | 0.060 |
Why?
|
| Microscopy, Electron | 4 | 1992 | 600 | 0.060 |
Why?
|
| Hearing Loss | 1 | 2006 | 153 | 0.060 |
Why?
|
| Case-Control Studies | 3 | 2012 | 6100 | 0.060 |
Why?
|
| Virus Diseases | 2 | 2011 | 398 | 0.060 |
Why?
|
| Age Factors | 3 | 2006 | 5377 | 0.060 |
Why?
|
| Sequence Analysis, DNA | 2 | 2009 | 2483 | 0.060 |
Why?
|
| Length of Stay | 3 | 2018 | 1900 | 0.060 |
Why?
|
| Communicable Diseases, Emerging | 1 | 2005 | 87 | 0.060 |
Why?
|
| Bacterial Outer Membrane Proteins | 4 | 1989 | 122 | 0.060 |
Why?
|
| Pharynx | 3 | 1982 | 153 | 0.060 |
Why?
|
| Azithromycin | 1 | 2004 | 78 | 0.060 |
Why?
|
| Virulence Factors | 2 | 2018 | 213 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2012 | 7702 | 0.060 |
Why?
|
| Musculoskeletal Diseases | 1 | 2004 | 81 | 0.060 |
Why?
|
| Intensive Care Units, Neonatal | 2 | 1998 | 273 | 0.060 |
Why?
|
| Macrolides | 1 | 2003 | 62 | 0.060 |
Why?
|
| Urban Health | 3 | 1997 | 75 | 0.060 |
Why?
|
| Influenza, Human | 1 | 2010 | 925 | 0.060 |
Why?
|
| Endocarditis, Bacterial | 1 | 2004 | 128 | 0.050 |
Why?
|
| Middle Aged | 11 | 2015 | 86204 | 0.050 |
Why?
|
| Hospitals, University | 1 | 2003 | 209 | 0.050 |
Why?
|
| Diseases in Twins | 1 | 1983 | 99 | 0.050 |
Why?
|
| Venous Thrombosis | 1 | 2006 | 384 | 0.050 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2005 | 275 | 0.050 |
Why?
|
| Respiration, Artificial | 2 | 1996 | 577 | 0.050 |
Why?
|
| Staphylococcus epidermidis | 2 | 1993 | 61 | 0.050 |
Why?
|
| Treatment Failure | 2 | 2004 | 1391 | 0.050 |
Why?
|
| Immunity, Maternally-Acquired | 1 | 2001 | 48 | 0.050 |
Why?
|
| Disease Models, Animal | 3 | 1991 | 7222 | 0.050 |
Why?
|
| Pharmacogenetics | 1 | 2003 | 260 | 0.050 |
Why?
|
| Bronchitis, Chronic | 1 | 2001 | 30 | 0.050 |
Why?
|
| Splenectomy | 1 | 2002 | 158 | 0.050 |
Why?
|
| Escherichia coli Infections | 4 | 1995 | 241 | 0.050 |
Why?
|
| Rupture, Spontaneous | 2 | 1991 | 70 | 0.050 |
Why?
|
| Otitis Media with Effusion | 1 | 2001 | 20 | 0.050 |
Why?
|
| Birth Weight | 5 | 1996 | 374 | 0.050 |
Why?
|
| Virulence | 3 | 2005 | 323 | 0.050 |
Why?
|
| Aged | 7 | 2015 | 70117 | 0.050 |
Why?
|
| Facial Dermatoses | 1 | 2000 | 26 | 0.050 |
Why?
|
| Stenotrophomonas maltophilia | 1 | 2000 | 31 | 0.050 |
Why?
|
| Legionella | 1 | 1980 | 18 | 0.050 |
Why?
|
| Ear, Inner | 2 | 1991 | 57 | 0.050 |
Why?
|
| Specific Pathogen-Free Organisms | 2 | 1991 | 93 | 0.050 |
Why?
|
| Cohort Studies | 4 | 2016 | 9244 | 0.050 |
Why?
|
| Linezolid | 2 | 1999 | 64 | 0.050 |
Why?
|
| Pentosephosphates | 3 | 1992 | 11 | 0.050 |
Why?
|
| Candidiasis | 2 | 1996 | 262 | 0.050 |
Why?
|
| Diabetes Mellitus | 2 | 2006 | 1054 | 0.050 |
Why?
|
| Streptococcus pyogenes | 2 | 2011 | 119 | 0.040 |
Why?
|
| Spleen | 1 | 2002 | 676 | 0.040 |
Why?
|
| Secondary Prevention | 1 | 2001 | 329 | 0.040 |
Why?
|
| Immunoglobulin A | 2 | 1997 | 237 | 0.040 |
Why?
|
| Serratia Infections | 1 | 1998 | 15 | 0.040 |
Why?
|
| Milk, Human | 2 | 2001 | 277 | 0.040 |
Why?
|
| Serratia marcescens | 1 | 1998 | 21 | 0.040 |
Why?
|
| Respiratory Tract Infections | 1 | 2003 | 437 | 0.040 |
Why?
|
| Kinetics | 8 | 1992 | 2049 | 0.040 |
Why?
|
| Flavobacterium | 1 | 1998 | 2 | 0.040 |
Why?
|
| Phenotype | 3 | 2003 | 6295 | 0.040 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2016 | 6550 | 0.040 |
Why?
|
| Food Preservation | 1 | 1997 | 5 | 0.040 |
Why?
|
| Bilirubin | 1 | 1979 | 221 | 0.040 |
Why?
|
| Drug Administration Schedule | 4 | 2005 | 3472 | 0.040 |
Why?
|
| Drug Synergism | 5 | 1998 | 1313 | 0.040 |
Why?
|
| Infection Control | 2 | 2015 | 270 | 0.040 |
Why?
|
| Referral and Consultation | 1 | 2003 | 899 | 0.040 |
Why?
|
| Bacterial Capsules | 1 | 2016 | 39 | 0.040 |
Why?
|
| Food, Fortified | 1 | 1997 | 95 | 0.040 |
Why?
|
| Cytomegalovirus Infections | 2 | 1980 | 462 | 0.040 |
Why?
|
| Sex Distribution | 2 | 2010 | 495 | 0.040 |
Why?
|
| Cholera | 1 | 1996 | 27 | 0.040 |
Why?
|
| Neoplasms | 2 | 2013 | 15193 | 0.030 |
Why?
|
| beta-Lactam Resistance | 1 | 1996 | 44 | 0.030 |
Why?
|
| Chronic Disease | 3 | 2014 | 1819 | 0.030 |
Why?
|
| Adhesins, Bacterial | 2 | 2006 | 85 | 0.030 |
Why?
|
| Reference Standards | 1 | 1996 | 339 | 0.030 |
Why?
|
| Species Specificity | 3 | 1992 | 777 | 0.030 |
Why?
|
| Follow-Up Studies | 7 | 2013 | 14889 | 0.030 |
Why?
|
| Hearing Loss, Sensorineural | 2 | 1995 | 144 | 0.030 |
Why?
|
| Epidemiological Monitoring | 1 | 2015 | 73 | 0.030 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2018 | 544 | 0.030 |
Why?
|
| Gestational Age | 4 | 1996 | 1069 | 0.030 |
Why?
|
| Animals | 14 | 2006 | 59536 | 0.030 |
Why?
|
| Heart Transplantation | 1 | 2001 | 908 | 0.030 |
Why?
|
| Coagulase | 2 | 1994 | 29 | 0.030 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2003 | 1021 | 0.030 |
Why?
|
| Jejunoileal Bypass | 1 | 1993 | 7 | 0.030 |
Why?
|
| Radiography | 1 | 1998 | 1904 | 0.030 |
Why?
|
| Pseudomonas Infections | 1 | 1995 | 156 | 0.030 |
Why?
|
| Amikacin | 2 | 1993 | 34 | 0.030 |
Why?
|
| Necrosis | 2 | 2008 | 580 | 0.030 |
Why?
|
| Brain Damage, Chronic | 1 | 2013 | 37 | 0.030 |
Why?
|
| Fetal Blood | 1 | 1976 | 482 | 0.030 |
Why?
|
| Eczema | 1 | 2013 | 37 | 0.030 |
Why?
|
| Blood | 1 | 2014 | 156 | 0.030 |
Why?
|
| Cross-Sectional Studies | 2 | 2013 | 4314 | 0.030 |
Why?
|
| Respirovirus Infections | 1 | 1993 | 35 | 0.030 |
Why?
|
| Risk | 1 | 1997 | 1972 | 0.030 |
Why?
|
| Neurologic Examination | 1 | 2013 | 245 | 0.030 |
Why?
|
| Administration, Oral | 2 | 1995 | 1544 | 0.030 |
Why?
|
| Epithelium | 3 | 1992 | 720 | 0.030 |
Why?
|
| Cerebrospinal Fluid Proteins | 2 | 1990 | 26 | 0.030 |
Why?
|
| DNA Primers | 1 | 1995 | 1399 | 0.030 |
Why?
|
| Glycemic Index | 1 | 2012 | 29 | 0.030 |
Why?
|
| Quinine | 1 | 2012 | 8 | 0.030 |
Why?
|
| Probability | 2 | 2005 | 866 | 0.030 |
Why?
|
| Otitis | 1 | 2012 | 8 | 0.030 |
Why?
|
| Base Sequence | 3 | 2007 | 4917 | 0.030 |
Why?
|
| Sputum | 2 | 2003 | 141 | 0.030 |
Why?
|
| Obesity | 1 | 2005 | 2884 | 0.030 |
Why?
|
| Respiratory Syncytial Viruses | 1 | 1993 | 171 | 0.030 |
Why?
|
| RNA, Bacterial | 1 | 2012 | 80 | 0.030 |
Why?
|
| Genes, Essential | 1 | 2012 | 48 | 0.030 |
Why?
|
| Evolution, Molecular | 1 | 2016 | 834 | 0.030 |
Why?
|
| Opsonin Proteins | 2 | 2001 | 15 | 0.030 |
Why?
|
| Molecular Sequence Data | 3 | 2007 | 6089 | 0.030 |
Why?
|
| Severity of Illness Index | 3 | 2010 | 4320 | 0.030 |
Why?
|
| Ampicillin Resistance | 1 | 1991 | 10 | 0.030 |
Why?
|
| Subdural Effusion | 1 | 1991 | 10 | 0.020 |
Why?
|
| Mycoplasma pneumoniae | 1 | 2011 | 13 | 0.020 |
Why?
|
| Cheek | 2 | 1989 | 70 | 0.020 |
Why?
|
| Epiglottitis | 1 | 1991 | 16 | 0.020 |
Why?
|
| Molecular Typing | 1 | 2011 | 55 | 0.020 |
Why?
|
| Double-Blind Method | 2 | 2001 | 2588 | 0.020 |
Why?
|
| Hearing Loss, Bilateral | 1 | 1991 | 13 | 0.020 |
Why?
|
| Gadolinium DTPA | 1 | 2012 | 172 | 0.020 |
Why?
|
| Osteoarthritis | 1 | 2012 | 94 | 0.020 |
Why?
|
| Endoscopy | 1 | 2014 | 479 | 0.020 |
Why?
|
| Catheterization, Central Venous | 1 | 1994 | 354 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 1998 | 4298 | 0.020 |
Why?
|
| Genes, Bacterial | 1 | 2012 | 236 | 0.020 |
Why?
|
| Temporal Bone | 2 | 2008 | 102 | 0.020 |
Why?
|
| Risk Assessment | 3 | 2012 | 6869 | 0.020 |
Why?
|
| Erythrocyte Count | 1 | 1990 | 38 | 0.020 |
Why?
|
| Phagocytosis | 4 | 2001 | 260 | 0.020 |
Why?
|
| Drug Evaluation | 1 | 1991 | 425 | 0.020 |
Why?
|
| Hemadsorption | 1 | 1990 | 6 | 0.020 |
Why?
|
| Bacteriophage Typing | 1 | 1989 | 3 | 0.020 |
Why?
|
| Cause of Death | 1 | 2013 | 752 | 0.020 |
Why?
|
| Mice, Mutant Strains | 3 | 1996 | 634 | 0.020 |
Why?
|
| Synovial Fluid | 1 | 2009 | 27 | 0.020 |
Why?
|
| Appendectomy | 1 | 1991 | 124 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 1998 | 4892 | 0.020 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2012 | 490 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2012 | 6009 | 0.020 |
Why?
|
| In Vitro Techniques | 2 | 1989 | 1618 | 0.020 |
Why?
|
| Gastric Bypass | 2 | 2005 | 81 | 0.020 |
Why?
|
| Polysaccharides | 2 | 1988 | 197 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 3 | 2001 | 1062 | 0.020 |
Why?
|
| Prognosis | 4 | 2013 | 21713 | 0.020 |
Why?
|
| Phylogeny | 1 | 2012 | 826 | 0.020 |
Why?
|
| Organ Culture Techniques | 1 | 1990 | 241 | 0.020 |
Why?
|
| Combined Modality Therapy | 2 | 1991 | 8865 | 0.020 |
Why?
|
| Enterobacteriaceae Infections | 1 | 1989 | 69 | 0.020 |
Why?
|
| Cerebrospinal Fluid Shunts | 1 | 1989 | 71 | 0.020 |
Why?
|
| Mucous Membrane | 1 | 1990 | 271 | 0.020 |
Why?
|
| Diphtheria Toxoid | 1 | 1988 | 12 | 0.020 |
Why?
|
| Pleural Effusion | 2 | 2002 | 201 | 0.020 |
Why?
|
| Immunoglobulin G | 2 | 2003 | 1021 | 0.020 |
Why?
|
| Adhesiveness | 2 | 1985 | 10 | 0.020 |
Why?
|
| Leukocytosis | 2 | 2000 | 112 | 0.020 |
Why?
|
| Administration, Intranasal | 1 | 1988 | 190 | 0.020 |
Why?
|
| Endothelium, Vascular | 1 | 1992 | 891 | 0.020 |
Why?
|
| Genomic Islands | 1 | 2007 | 32 | 0.020 |
Why?
|
| Complement Pathway, Alternative | 1 | 1987 | 20 | 0.020 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 2003 | 419 | 0.020 |
Why?
|
| Molecular Weight | 2 | 1985 | 629 | 0.020 |
Why?
|
| Half-Life | 2 | 1985 | 259 | 0.020 |
Why?
|
| Complement Activation | 1 | 1987 | 94 | 0.020 |
Why?
|
| Gram-Positive Bacteria | 1 | 1987 | 66 | 0.020 |
Why?
|
| Open Reading Frames | 1 | 2007 | 250 | 0.020 |
Why?
|
| Hydrolases | 1 | 2007 | 123 | 0.020 |
Why?
|
| Critical Care | 1 | 2013 | 770 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 1991 | 945 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 1990 | 1382 | 0.020 |
Why?
|
| Sex Factors | 2 | 2006 | 2139 | 0.020 |
Why?
|
| Biopsy, Needle | 1 | 2011 | 1363 | 0.020 |
Why?
|
| Monocytes | 1 | 1990 | 788 | 0.020 |
Why?
|
| Polymyxins | 1 | 1986 | 19 | 0.020 |
Why?
|
| Horses | 1 | 2006 | 96 | 0.020 |
Why?
|
| Endotoxins | 1 | 1986 | 96 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2003 | 1489 | 0.020 |
Why?
|
| Health | 1 | 2006 | 54 | 0.020 |
Why?
|
| Amphotericin B | 1 | 1987 | 289 | 0.020 |
Why?
|
| Polymyxin B | 1 | 1986 | 53 | 0.020 |
Why?
|
| Plasmids | 1 | 2007 | 837 | 0.020 |
Why?
|
| Lymphocytes | 1 | 1990 | 1234 | 0.020 |
Why?
|
| Carbohydrates | 1 | 1985 | 68 | 0.020 |
Why?
|
| Streptococcus | 2 | 1987 | 68 | 0.020 |
Why?
|
| Anastomosis, Roux-en-Y | 1 | 2005 | 14 | 0.020 |
Why?
|
| Sampling Studies | 1 | 2005 | 170 | 0.020 |
Why?
|
| Contrast Media | 1 | 2012 | 1472 | 0.020 |
Why?
|
| Electrophoresis | 2 | 1995 | 60 | 0.020 |
Why?
|
| Infusions, Parenteral | 1 | 1985 | 191 | 0.020 |
Why?
|
| Nasal Mucosa | 2 | 2001 | 94 | 0.020 |
Why?
|
| Pneumonia | 1 | 1991 | 751 | 0.020 |
Why?
|
| Genetic Variation | 1 | 1993 | 2086 | 0.020 |
Why?
|
| Pregnancy | 6 | 2003 | 7573 | 0.020 |
Why?
|
| Survival Rate | 4 | 2005 | 12221 | 0.020 |
Why?
|
| Muramoylpentapeptide Carboxypeptidase | 1 | 2003 | 5 | 0.020 |
Why?
|
| Peptidyl Transferases | 1 | 2003 | 6 | 0.020 |
Why?
|
| Penicillin-Binding Proteins | 1 | 2003 | 12 | 0.020 |
Why?
|
| Hexosyltransferases | 1 | 2003 | 10 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 1990 | 3033 | 0.010 |
Why?
|
| Glucose | 1 | 1990 | 1248 | 0.010 |
Why?
|
| Chemotaxis | 1 | 1984 | 138 | 0.010 |
Why?
|
| Clone Cells | 1 | 2005 | 555 | 0.010 |
Why?
|
| Escherichia coli | 2 | 1988 | 1203 | 0.010 |
Why?
|
| Bronchopulmonary Dysplasia | 2 | 1996 | 161 | 0.010 |
Why?
|
| Survival Analysis | 3 | 2005 | 9180 | 0.010 |
Why?
|
| Anuria | 1 | 1983 | 14 | 0.010 |
Why?
|
| Demography | 1 | 2004 | 435 | 0.010 |
Why?
|
| Lung Abscess | 1 | 2002 | 13 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 2005 | 829 | 0.010 |
Why?
|
| Umbilical Cord | 2 | 1980 | 54 | 0.010 |
Why?
|
| Radiopharmaceuticals | 1 | 2008 | 1301 | 0.010 |
Why?
|
| Pulmonary Embolism | 1 | 2006 | 329 | 0.010 |
Why?
|
| Nafcillin | 1 | 1982 | 12 | 0.010 |
Why?
|
| Epidemiologic Studies | 1 | 2002 | 60 | 0.010 |
Why?
|
| Blotting, Western | 1 | 1988 | 3536 | 0.010 |
Why?
|
| Bronchoalveolar Lavage | 1 | 2001 | 53 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2007 | 1450 | 0.010 |
Why?
|
| Viruses | 1 | 2003 | 159 | 0.010 |
Why?
|
| Ribotyping | 1 | 2001 | 48 | 0.010 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2001 | 124 | 0.010 |
Why?
|
| Penicillin G Procaine | 1 | 1981 | 1 | 0.010 |
Why?
|
| Age of Onset | 1 | 2003 | 827 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2011 | 4744 | 0.010 |
Why?
|
| Penicillin G | 1 | 2001 | 10 | 0.010 |
Why?
|
| Reference Values | 1 | 2003 | 1099 | 0.010 |
Why?
|
| Mouth Mucosa | 1 | 1982 | 216 | 0.010 |
Why?
|
| Syphilis, Congenital | 1 | 1981 | 25 | 0.010 |
Why?
|
| Schools | 1 | 1982 | 233 | 0.010 |
Why?
|
| Kidney | 2 | 1996 | 2146 | 0.010 |
Why?
|
| Causality | 1 | 2000 | 178 | 0.010 |
Why?
|
| NAD | 1 | 1980 | 89 | 0.010 |
Why?
|
| Cerebrospinal Fluid | 1 | 2000 | 120 | 0.010 |
Why?
|
| Luminescent Measurements | 3 | 1987 | 148 | 0.010 |
Why?
|
| Medical Records | 1 | 2001 | 415 | 0.010 |
Why?
|
| Safety | 1 | 2001 | 465 | 0.010 |
Why?
|
| Maternal-Fetal Exchange | 1 | 1980 | 90 | 0.010 |
Why?
|
| Charcoal | 1 | 1979 | 8 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2001 | 1037 | 0.010 |
Why?
|
| Methods | 1 | 1979 | 189 | 0.010 |
Why?
|
| Spectrophotometry | 1 | 1979 | 82 | 0.010 |
Why?
|
| Bronchoscopy | 1 | 2001 | 474 | 0.010 |
Why?
|
| Vagina | 1 | 1980 | 317 | 0.010 |
Why?
|
| Food Contamination | 1 | 1997 | 22 | 0.010 |
Why?
|
| Freezing | 1 | 1997 | 59 | 0.010 |
Why?
|
| Refrigeration | 1 | 1997 | 15 | 0.010 |
Why?
|
| Puerperal Infection | 1 | 1977 | 8 | 0.010 |
Why?
|
| Colony Count, Microbial | 1 | 1997 | 149 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 1997 | 204 | 0.010 |
Why?
|
| Immunodiffusion | 1 | 1976 | 46 | 0.010 |
Why?
|
| Enterotoxins | 1 | 1977 | 112 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2005 | 2203 | 0.010 |
Why?
|
| Mozambique | 1 | 1996 | 16 | 0.010 |
Why?
|
| Respiratory Tract Diseases | 1 | 1997 | 111 | 0.010 |
Why?
|
| Phagocytes | 1 | 1996 | 44 | 0.010 |
Why?
|
| Enterocolitis, Pseudomembranous | 1 | 1977 | 111 | 0.010 |
Why?
|
| Rural Health | 1 | 1996 | 51 | 0.010 |
Why?
|
| British Columbia | 1 | 1996 | 24 | 0.010 |
Why?
|
| Nurseries, Hospital | 2 | 1991 | 6 | 0.010 |
Why?
|
| Refugees | 1 | 1996 | 29 | 0.010 |
Why?
|
| Infant Mortality | 1 | 1997 | 186 | 0.010 |
Why?
|
| Fungemia | 1 | 1996 | 116 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2008 | 7551 | 0.010 |
Why?
|
| Immunoglobulin M | 1 | 1976 | 347 | 0.010 |
Why?
|
| Autoanalysis | 1 | 1995 | 7 | 0.010 |
Why?
|
| Renal Dialysis | 1 | 1983 | 945 | 0.010 |
Why?
|
| Smoking | 1 | 2005 | 2440 | 0.010 |
Why?
|
| Skin Diseases, Bacterial | 1 | 1995 | 44 | 0.010 |
Why?
|
| Colorimetry | 1 | 1995 | 31 | 0.010 |
Why?
|
| Injections, Intravenous | 2 | 1989 | 573 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2003 | 2022 | 0.010 |
Why?
|
| Hypertension | 1 | 2005 | 1503 | 0.010 |
Why?
|
| Meninges | 1 | 1995 | 47 | 0.010 |
Why?
|
| Ambulatory Care | 1 | 1998 | 554 | 0.010 |
Why?
|
| Models, Biological | 2 | 1993 | 3254 | 0.010 |
Why?
|
| Diffusion | 1 | 1993 | 88 | 0.010 |
Why?
|
| Drug Implants | 1 | 1993 | 46 | 0.010 |
Why?
|
| Biopsy | 1 | 2001 | 3443 | 0.010 |
Why?
|
| Random Allocation | 2 | 1988 | 703 | 0.010 |
Why?
|
| Diarrhea | 1 | 1997 | 686 | 0.010 |
Why?
|
| Triage | 1 | 1995 | 252 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 1997 | 2307 | 0.010 |
Why?
|
| Umbilical Veins | 1 | 1992 | 115 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 1995 | 538 | 0.010 |
Why?
|
| Sheep | 1 | 1993 | 258 | 0.010 |
Why?
|
| Child Development | 1 | 1995 | 255 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1993 | 548 | 0.010 |
Why?
|
| Weight Loss | 1 | 1996 | 627 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2011 | 29902 | 0.010 |
Why?
|
| Regional Health Planning | 1 | 1991 | 8 | 0.010 |
Why?
|
| Intensive Care, Neonatal | 1 | 1991 | 53 | 0.010 |
Why?
|
| Audiometry, Evoked Response | 1 | 1990 | 4 | 0.010 |
Why?
|
| Cerebrospinal Fluid Otorrhea | 1 | 1990 | 5 | 0.010 |
Why?
|
| Clinical Trials as Topic | 3 | 1988 | 3719 | 0.010 |
Why?
|
| Mice | 3 | 1996 | 34495 | 0.010 |
Why?
|
| Nervous System Diseases | 1 | 1995 | 500 | 0.010 |
Why?
|
| Models, Statistical | 1 | 1996 | 1171 | 0.010 |
Why?
|
| Patient Transfer | 1 | 1991 | 137 | 0.010 |
Why?
|
| Maternal Age | 2 | 1980 | 152 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 1995 | 1538 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1989 | 568 | 0.010 |
Why?
|
| Hemolysin Proteins | 1 | 1988 | 27 | 0.000 |
Why?
|
| Penicillinase | 1 | 1987 | 2 | 0.000 |
Why?
|
| Salmonella typhimurium | 1 | 1987 | 70 | 0.000 |
Why?
|
| Cell Movement | 1 | 1995 | 2466 | 0.000 |
Why?
|
| Mice, Transgenic | 1 | 1995 | 4143 | 0.000 |
Why?
|
| Hemolysis | 1 | 1987 | 127 | 0.000 |
Why?
|
| Daptomycin | 1 | 1987 | 39 | 0.000 |
Why?
|
| Cochlear Duct | 1 | 1986 | 5 | 0.000 |
Why?
|
| Organ of Corti | 1 | 1986 | 22 | 0.000 |
Why?
|
| Body Fluids | 1 | 1987 | 125 | 0.000 |
Why?
|
| Tissue Distribution | 1 | 1987 | 875 | 0.000 |
Why?
|
| Tumor Cells, Cultured | 1 | 1992 | 5395 | 0.000 |
Why?
|
| Superoxides | 1 | 1985 | 211 | 0.000 |
Why?
|
| Complement C5 | 1 | 1984 | 15 | 0.000 |
Why?
|
| Immune Adherence Reaction | 1 | 1983 | 4 | 0.000 |
Why?
|
| Complement C5a | 1 | 1984 | 36 | 0.000 |
Why?
|
| Adsorption | 1 | 1983 | 46 | 0.000 |
Why?
|
| Cells, Cultured | 1 | 1992 | 5637 | 0.000 |
Why?
|
| Radioimmunoassay | 1 | 1983 | 191 | 0.000 |
Why?
|
| Blood Cell Count | 1 | 1984 | 225 | 0.000 |
Why?
|
| Developmental Disabilities | 1 | 1988 | 674 | 0.000 |
Why?
|
| Brain | 1 | 1996 | 4113 | 0.000 |
Why?
|
| Drug Antagonism | 1 | 1981 | 32 | 0.000 |
Why?
|
| Klebsiella Infections | 1 | 1982 | 64 | 0.000 |
Why?
|
| Neurosyphilis | 1 | 1981 | 9 | 0.000 |
Why?
|
| Peptides | 1 | 1987 | 1479 | 0.000 |
Why?
|
| Hemorrhage | 1 | 1986 | 712 | 0.000 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1982 | 585 | 0.000 |
Why?
|
| Injections, Intramuscular | 1 | 1981 | 255 | 0.000 |
Why?
|
| Ear | 1 | 1980 | 38 | 0.000 |
Why?
|
| Cephalometry | 1 | 1980 | 39 | 0.000 |
Why?
|
| Temperature | 1 | 1982 | 506 | 0.000 |
Why?
|
| Biological Assay | 1 | 1981 | 177 | 0.000 |
Why?
|
| Silver Sulfadiazine | 1 | 1979 | 15 | 0.000 |
Why?
|
| Soaps | 1 | 1979 | 7 | 0.000 |
Why?
|
| Gentian Violet | 1 | 1979 | 20 | 0.000 |
Why?
|
| Blood-Brain Barrier | 1 | 1981 | 238 | 0.000 |
Why?
|
| Regression Analysis | 1 | 1983 | 1546 | 0.000 |
Why?
|
| Body Height | 1 | 1980 | 231 | 0.000 |
Why?
|
| Coloring Agents | 1 | 1979 | 234 | 0.000 |
Why?
|
| Enterotoxemia | 1 | 1977 | 1 | 0.000 |
Why?
|
| Rectum | 1 | 1980 | 467 | 0.000 |
Why?
|
| Diarrhea, Infantile | 1 | 1977 | 43 | 0.000 |
Why?
|
| Disease Reservoirs | 1 | 1977 | 42 | 0.000 |
Why?
|
| Personnel, Hospital | 1 | 1977 | 40 | 0.000 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 1992 | 5437 | 0.000 |
Why?
|
| Socioeconomic Factors | 1 | 1980 | 1225 | 0.000 |
Why?
|
| Pregnancy Complications | 1 | 1980 | 526 | 0.000 |
Why?
|
| Longitudinal Studies | 1 | 1980 | 1945 | 0.000 |
Why?
|
| Kidney Failure, Chronic | 1 | 1983 | 960 | 0.000 |
Why?
|
| Feces | 1 | 1977 | 770 | 0.000 |
Why?
|
| Membrane Proteins | 1 | 1983 | 2819 | 0.000 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1981 | 4938 | 0.000 |
Why?
|